Department of Cardiothoracic Surgery, Cologne Heart Center, University of Cologne, Cologne, Germany.
Ann Thorac Surg. 2010 Dec;90(6):2035-7. doi: 10.1016/j.athoracsur.2010.06.059.
This case report illustrates our experience with transapical minimally invasive aortic valve implantation in a patient with an extended aneurysm of the thoracoabdominal aorta, who had previously undergone a replacement of the ascending aorta with concomitant aortic valve reconstruction (David procedure). Endovascular stent grafting of the descending aorta was also performed. The implantation of a 23-mm SAPIEN valve (Edwards Lifesciences, Irvine, CA) did not interfere with the existing 26-mm aortic Hemashield prosthesis (Boston Scientific, Natick, MA) or the previously implanted endograft in the descending aortic position. No paravalvular leakage with aortic valve regurgitation, prosthesis instability, or coronary malperfusion was seen after valve implementation.
本病例报告阐述了我们在一位胸主动脉腹主动脉广泛瘤患者中经心尖微创主动脉瓣植入的经验,该患者曾行升主动脉置换术,同期行主动脉瓣重建(David 手术)。还对降主动脉进行了血管内支架移植物置入。植入一枚 23 毫米的 SAPIEN 瓣膜(爱德华生命科学公司,尔湾,加利福尼亚州)不会干扰现有的 26 毫米主动脉 Hemashield 假体(波士顿科学公司,纳提克,马萨诸塞州)或先前植入的降主动脉内的移植物。瓣膜植入后未见瓣周漏、人工瓣膜不稳定或冠状动脉灌注不良。